Posted by Solstice on February 28, 2012, at 11:34:47
In reply to corection: correction- Lou's reply-agranulocytosis, posted by Lou Pilder on February 27, 2012, at 23:02:28
Lou -
I guess you are aware that your link's Clinical Investigation reiterates what Scott said - that since Saphris is not activating the 5-HT2b receptors, it is not implicated in agranulocytosis.
Solstice
> > > Scott,
> > > Saphris is a newer drug so the reports are not many yet as a drug like Prozac. Neutropenia is more eventfull than agranulocytosis, but as more time runs there could be more reports of that event.
> > > Now what is the chemical concerning receptors are the matabolites. This could change things a bit...
> > > Now here is a report that I think could be of help here. I have the report on deaths with saphris in the trials and will put that together later.
> > > Lou
> > > http://circ.ahjournals.org/content/1022/23/2836.full
> > corrected:
> > http://circ.ahjournals.org/content/102/23/2836.full
>
> correction:
> http://circ.ahajournals.org/content/102/23/2836.full
poster:Solstice
thread:1011122
URL: http://www.dr-bob.org/babble/20120221/msgs/1011907.html